eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR was delisted on the 2nd of July, 2024.
25 hedge funds and large institutions have $5.49M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
14% less funds holding
Funds holding: 29 → 25 (-4)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
61% less capital invested
Capital invested by funds: $14M → $5.49M (-$8.49M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$77.3K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$66.5K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$53.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$33.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOCM
SR One Capital Management
Wayne,
Pennsylvania
|
-$4.03M |
| 2 |
CG
Column Group
San Francisco,
California
|
-$2.42M |
| 3 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$158K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.5K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$18.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SOA
26
Sea Otter Advisors
Miami,
Florida
| – | -$158K | -10,558 | Closed |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$26.5K | -1,976 | Closed |
|
|
EWA
28
EP Wealth Advisors
Torrance,
California
| – | -$18.6K | -1,240 | Closed |
|
29
Renaissance Technologies
New York
| – | -$17K | -1,131 | Closed |
|
|
MOS
30
MGO One Seven
Beachwood,
Ohio
| – | -$12K | -803 | Closed |
|
31
Millennium Management
New York
| – | -$8.38K | -558 | Closed |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$134 | -10 | -63% |
|
33
Barclays
London,
United Kingdom
| – | -$49 | -3 | Closed |
|
34
Simplex Trading
Chicago,
Illinois
| – | +$925 | +69 | New |
|
EFTR Hedge Fund Activity: Q4 2023 in Review
25 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Common Stock (EFTR) for Q4 2023, worth a combined $5.49M — down 61% from $14M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of EFTR and 6 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $91.4K. The largest seller was SR One Capital Management, exiting entirely with an estimated $4.03M sold.
- 25 institutional investors held eFFECTOR Therapeutics, Inc. Common Stock (EFTR) as of Q4 2023, down from 29 in Q3 2023.
- Funds reported $5.49M of eFFECTOR Therapeutics, Inc. Common Stock stock for Q4 2023, down 61% quarter-over-quarter.
- 6 funds opened new eFFECTOR Therapeutics, Inc. Common Stock positions in Q4 2023 and 9 closed out, a net change of -3 holders.
- The largest eFFECTOR Therapeutics, Inc. Common Stock buyer in Q4 2023 was Vanguard Group, an estimated $91.4K added.
- The largest eFFECTOR Therapeutics, Inc. Common Stock seller in Q4 2023 was SR One Capital Management, an estimated $4.03M sold.
Based on aggregated 13F filings for Q4 2023.